Catalyst Pharmaceuticals (CPRX) Institutional Ownership $21.08 +0.52 (+2.53%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$21.09 +0.01 (+0.07%) As of 08/22/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Catalyst Pharmaceuticals (NASDAQ:CPRX)CurrentInstitutional OwnershipPercentage79.22%Number ofInstitutional Buyers(last 12 months)258TotalInstitutional Inflows(last 12 months)$545.50MNumber ofInstitutional Sellers(last 12 months)162TotalInstitutional Outflows(last 12 months)$351.11M Get CPRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Catalyst Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CPRX Institutional Buying and Selling by Quarter Catalyst Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/19/2025 Cim LLC23,333$506K0.1%-9.7%0.019% 8/19/2025 State of Wyoming18,155$394K0.0%+43.6%0.015% 8/19/2025 Hohimer Wealth Management LLC11,974$260K0.0%-33.7%0.010% 8/18/2025 Nomura Holdings Inc.88,821$1.93M0.0%+321.3%0.073% 8/18/2025 Castleark Management LLC48,520$1.05M0.0%-71.8%0.040% 8/16/2025 Public Sector Pension Investment Board466,402$10.12M0.0%+13.5%0.381% 8/15/2025 CANADA LIFE ASSURANCE Co127,700$2.77M0.0%+4.7%0.104% 8/15/2025 Tower Research Capital LLC TRC 12,444$270K0.0%+3,227.3%0.010% 8/15/2025 State of Tennessee Department of Treasury48,867$1.06M0.0%-1.9%0.040% 8/15/2025 E Fund Management Co. Ltd.10,656$231K0.0%+8.9%0.009% Get the Latest News and Ratings for CPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Catalyst Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/15/2025 Captrust Financial Advisors21,748$472K0.0%N/A0.018% 8/15/2025 Tidal Investments LLC46,216$1.00M0.0%+7.9%0.038% 8/15/2025 Rafferty Asset Management LLC95,716$2.08M0.0%-8.6%0.078% 8/15/2025 Oxford Asset Management LLP20,201$438K0.2%N/A0.017% 8/15/2025 Man Group plc430,904$9.35M0.0%+45.7%0.352% 8/15/2025 Lazard Asset Management LLC43,969$953K0.0%-74.6%0.036% 8/15/2025 Engineers Gate Manager LP56,142$1.22M0.0%N/A0.046% 8/15/2025 BI Asset Management Fondsmaeglerselskab A S9,847$214K0.0%-30.9%0.008% 8/15/2025 BNP Paribas Financial Markets172,421$3.74M0.0%-6.3%0.141% 8/15/2025 Boothbay Fund Management LLC40,591$881K0.0%-26.0%0.033% 8/15/2025 Brevan Howard Capital Management LP18,176$394K0.0%N/A0.015% 8/15/2025 Bank of America Corp DE2,365,675$51.34M0.0%+30.6%1.933% 8/15/2025 Ameriprise Financial Inc.250,149$5.43M0.0%-7.1%0.204% 8/15/2025 AQR Capital Management LLC398,422$8.65M0.0%-10.6%0.326% 8/14/2025 Orbimed Advisors LLC416,900$9.05M0.2%N/A0.341% 8/14/2025 California State Teachers Retirement System99,257$2.15M0.0%+1.0%0.081% 8/14/2025 Raymond James Financial Inc.845,048$18.34M0.0%+91.8%0.690% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.68,188$1.48M0.0%-5.4%0.056% 8/14/2025 Globeflex Capital L P298,087$6.47M0.5%+17.3%0.244% 8/14/2025 The Manufacturers Life Insurance Company 61,605$1.34M0.0%-2.5%0.050% 8/14/2025 Squarepoint Ops LLC50,672$1.10M0.0%-32.1%0.041% 8/14/2025 Sei Investments Co.67,298$1.46M0.0%-42.2%0.055% 8/14/2025 Nebula Research & Development LLC20,418$443K0.0%+28.5%0.017% 8/14/2025 Qube Research & Technologies Ltd1,014,410$22.01M0.0%+33.4%0.829% 8/14/2025 iSAM Funds UK Ltd16,143$350K0.1%N/A0.013% 8/14/2025 State Street Corp5,478,388$118.88M0.0%-0.9%4.476% 8/14/2025 WINTON GROUP Ltd49,994$1.09M0.1%-11.9%0.041% 8/14/2025 Federated Hermes Inc.254,780$5.53M0.0%+242.1%0.208% 8/13/2025 Cresset Asset Management LLC87,418$1.90M0.0%+588.1%0.071% 8/13/2025 Amundi18,687$401K0.0%-58.6%0.015% The Coin That Could Define Trump’s Crypto Presidency (Ad)When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”Discover the coin that could define Trump’s crypto presidency.8/13/2025 Marshall Wace LLP140,823$3.06M0.0%N/A0.115% 8/13/2025 QSV Equity Investors LLC53,438$1.16M1.2%-36.3%0.044% 8/13/2025 Bridge City Capital LLC115,881$2.52M0.7%-1.3%0.095% 8/13/2025 First Trust Advisors LP302,280$6.56M0.0%+24.8%0.247% 8/13/2025 Kennedy Capital Management LLC1,009,461$21.91M0.5%-4.9%0.825% 8/13/2025 Invesco Ltd.1,213,700$26.34M0.0%+1.2%0.992% 8/13/2025 Systematic Financial Management LP194,630$4.22M0.1%+7.3%0.159% 8/13/2025 Arrowstreet Capital Limited Partnership1,223,623$26.55M0.0%+18.2%1.000% 8/13/2025 Quantbot Technologies LP17,903$388K0.0%+7.3%0.015% 8/13/2025 Fisher Asset Management LLC83,137$1.80M0.0%+1.2%0.068% 8/13/2025 Virtus Advisers LLC1,950$42K0.1%-91.4%0.002% 8/13/2025 New York State Common Retirement Fund65,196$1.42M0.0%-29.1%0.053% 8/13/2025 Skandinaviska Enskilda Banken AB publ 552,700$11.99M0.1%-29.8%0.452% 8/13/2025 Norges Bank13,766$299K0.0%N/A0.011% 8/13/2025 Hsbc Holdings PLC51,822$1.12M0.0%+48.2%0.042% 8/13/2025 Capital Fund Management S.A.80,071$1.74M0.0%+10.7%0.065% 8/13/2025 Advantage Alpha Capital Partners LP16,200$352K0.1%-19.1%0.013% 8/13/2025 Vinva Investment Management Ltd9,507$206K0.0%N/A0.008% 8/13/2025 Russell Investments Group Ltd.171,395$3.72M0.0%+20.9%0.140% 8/12/2025 Boston Partners1,282,722$27.93M0.0%+0.6%1.048% 8/12/2025 Elo Mutual Pension Insurance Co27,877$605K0.0%N/A0.023% 8/12/2025 Advisors Asset Management Inc.191,516$4.16M0.1%+7.1%0.156% 8/12/2025 CreativeOne Wealth LLC34,044$739K0.0%-6.9%0.028% 8/12/2025 Summit Global Investments56,415$1.22M0.1%-19.4%0.046% 8/12/2025 Prudential Financial Inc.376,384$8.17M0.0%-1.3%0.308% 8/12/2025 Cynosure Group LLC18,777$407K0.0%+22.2%0.015% 8/12/2025 American Century Companies Inc.1,757,988$38.15M0.0%+233.9%1.436% 8/12/2025 Segall Bryant & Hamill LLC80,844$1.75M0.0%-12.1%0.066% 8/12/2025 Rhumbline Advisers329,078$7.14M0.0%+6.0%0.269% 8/12/2025 Franklin Resources Inc.140,182$3.04M0.0%+77.4%0.115% 8/12/2025 Legal & General Group Plc663,595$14.40M0.0%+15.7%0.542% 8/12/2025 Hillsdale Investment Management Inc.264,800$5.75M0.2%+34.3%0.216% 8/12/2025 Neo Ivy Capital Management125,627$2.73M0.9%N/A0.103% 8/12/2025 JPMorgan Chase & Co.433,722$9.41M0.0%+23.0%0.354% 8/12/2025 Magnetar Financial LLC47,031$1.02M0.0%N/A0.038% 8/12/2025 Swiss National Bank221,300$4.80M0.0%+6.4%0.181% 8/12/2025 Handelsbanken Fonder AB32,077$696K0.0%-9.6%0.026% 8/11/2025 EMC Capital Management7,677$167K0.1%-48.0%0.006% 8/11/2025 Renaissance Group LLC329,057$7.14M0.3%+30.4%0.269% 8/11/2025 Wealthspire Advisors LLC36,879$800K0.0%+7.1%0.030% 8/11/2025 JW Asset Management LLC388,392$8.43M4.2%-6.0%0.317% 8/11/2025 Westover Capital Advisors LLC28,957$628K0.1%+135.7%0.024% 8/11/2025 LSV Asset Management577,700$12.54M0.0%-17.9%0.472% 8/11/2025 Knott David M Jr176,000$3.82M1.7%-17.0%0.144% 8/11/2025 Universal Beteiligungs und Servicegesellschaft mbH145,662$3.16M0.0%-14.7%0.119% 8/8/2025 Rockefeller Capital Management L.P.13,608$295K0.0%+31.2%0.011% 8/8/2025 Intech Investment Management LLC101,069$2.19M0.0%+44.2%0.083% 8/8/2025 Cetera Investment Advisers54,728$1.19M0.0%-5.9%0.045% 8/8/2025 Creative Planning16,385$356K0.0%+19.6%0.013% 8/8/2025 Commonwealth of Pennsylvania Public School Empls Retrmt SYS29,437$639K0.0%+9.7%0.024% Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the September 1st funding windo8/8/2025 Police & Firemen s Retirement System of New Jersey25,699$558K0.0%+4.3%0.021% 8/8/2025 Geode Capital Management LLC2,866,683$62.21M0.0%+3.7%2.350% 8/8/2025 KBC Group NV3,387$73K0.0%-27.9%0.003% 8/8/2025 Jupiter Asset Management Ltd.517,666$11.23M0.1%+6.0%0.424% 8/7/2025 Boston Partners1,282,722$27.93M0.0%+0.6%1.052% 8/7/2025 Allworth Financial LP20,972$455K0.0%+7,754.7%0.017% 8/7/2025 ProShare Advisors LLC25,821$560K0.0%-2.9%0.021% 8/7/2025 Profund Advisors LLC24,807$538K0.0%-4.6%0.020% 8/7/2025 Future Fund LLC26,789$581K0.3%N/A0.022% 8/7/2025 Campbell & CO Investment Adviser LLC43,541$945K0.1%-54.2%0.036% (Data available from 1/1/2016 forward) CPRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CPRX shares? During the previous two years, 357 institutional investors and hedge funds held shares of Catalyst Pharmaceuticals. The most heavily invested institutionals were Vanguard Group Inc. ($206.02M), State Street Corp ($118.88M), Goldman Sachs Group Inc. ($76.04M), Deerfield Management Company L.P. Series C ($65.39M), Dimensional Fund Advisors LP ($62.88M), Geode Capital Management LLC ($62.21M), and Renaissance Technologies LLC ($56.48M).Learn more on Catalyst Pharmaceuticals' institutional investors. What percentage of Catalyst Pharmaceuticals' stock is owned by institutional investors? 79.22% of Catalyst Pharmaceuticals' stock is owned by institutional investors. Learn more on CPRX's institutional investor holdings. Which institutional investors have been buying Catalyst Pharmaceuticals' stock? Of the 310 institutional investors that purchased Catalyst Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Pacer Advisors Inc. ($3.12M), Castlekeep Investment Advisors LLC ($1.88M), American Century Companies Inc. ($1.78M), Janus Henderson Group PLC ($1.70M), Vanguard Group Inc. ($1.56M), Bank of America Corp DE ($1.47M), and Boston Partners ($1.43M). How much institutional buying is happening at Catalyst Pharmaceuticals? Institutional investors have bought a total of 24,834,068 shares in the last 24 months. This purchase volume represents approximately $545.50M in transactions. Which of Catalyst Pharmaceuticals' major shareholders have been selling company stock? Of the 162 institutional investors that sold Catalyst Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Deerfield Management Company L.P. Series C ($3.10M), Pacer Advisors Inc. ($2.26M), Janus Henderson Group PLC ($1.82M), Jacobs Levy Equity Management Inc. ($835.12K), Marshall Wace LLP ($607.30K), Royce & Associates LP ($563.66K), and State Street Corp ($400.02K). How much institutional selling is happening at Catalyst Pharmaceuticals? Institutional investors have sold a total of 16,280,442 shares in the last 24 months. This volume of shares sold represents approximately $351.11M in transactions. Related Companies BBIO Major Shareholders VRNA Major Shareholders ELAN Major Shareholders BPMC Major Shareholders ROIV Major Shareholders GRFS Major Shareholders LEGN Major Shareholders RVMD Major Shareholders RYTM Major Shareholders RNA Major Shareholders This page (NASDAQ:CPRX) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalyst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catalyst Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access